๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Maintenance therapy in IBD

โœ Scribed by Dr. William J. Tremaine

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
1006 KB
Volume
4
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

General health maintenance in IBD
General health maintenance in IBD
โœ Maria Moscandrew; Uma Mahadevan; Sunanda Kane ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 116 KB

Patients with inflammatory bowel disease (IBD) often rely on their gastroenterologist for healthcare maintenance. In addition, the gastroenterologist also provides guidance to the patient's primary care physician on a broad range of issues such as vaccinations, osteoporosis screening, and cancer/dys

Role of probiotic therapy in IBD
Role of probiotic therapy in IBD
โœ Kim Isaacs; Hans Herfarth ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 105 KB

There is mounting evidence that probiotic therapy may alter disease expression in both animal models of IBD and in patients with IBD. The effects appear to be modest at best and may reflect the choice of probiotic organism, the variability in concentrations of organisms administered, and the variabi

Phenotype classification in IBD: Is ther
Phenotype classification in IBD: Is there an impact on therapy?
โœ Aaron Walfish; David Sachar ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 56 KB

This review summarizes the current phenotypic classifications of inflammatory bowel disease (IBD) and outlines their implications for diagnosis, therapy, prognosis, clinical trial design, and genotype-phenotype correlations.

IBD: A vascular disorder? the case for h
IBD: A vascular disorder? the case for heparin therapy
โœ Dr. Joshua R. Korzenik ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 864 KB

In recent years, heparin has emerged as a possible therapy for inflammatory bowel disease (IBD). Several recent, strongly positive, open-labeled series of heparin in both ulcerative colitis (UC) and Crohn's disease (CD) reinforce the work of Gaffney and co-workers that suggested a benefit of heparin